Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Monthly access flow monitoring with increased prophylactic angioplasty did not improve fistula patency.

Shahin H, Reddy G, Sharafuddin M, Katz D, Franzwa BS, Dixon BS.

Kidney Int. 2005 Nov;68(5):2352-61.

2.

The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trial.

Aragoncillo I, Amézquita Y, Caldés S, Abad S, Vega A, Cirugeda A, Moratilla C, Ibeas J, Roca-Tey R, Fernández C, Quiroga B, Blanco A, Villaverde M, Ruiz C, Martín B, Ruiz AM, Ampuero J, López-Gómez JM, de Alvaro F.

J Vasc Access. 2016 Jan-Feb;17(1):13-9. doi: 10.5301/jva.5000461. Epub 2015 Sep 18.

PMID:
26391583
3.

Reducing vascular access morbidity: a comparative trial of two vascular access monitoring strategies.

Lok CE, Bhola C, Croxford R, Richardson RM.

Nephrol Dial Transplant. 2003 Jun;18(6):1174-80.

PMID:
12748352
4.

Economic analysis of angiography and preemptive angioplasty to prevent hemodialysis-access thrombosis.

Bittl JA, Cohen DJ, Seek MM, Feldman RL.

Catheter Cardiovasc Interv. 2010 Jan 1;75(1):14-21. doi: 10.1002/ccd.22247.

PMID:
19862805
5.

Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.

Kakkos SK, Andrzejewski T, Haddad JA, Haddad GK, Reddy DJ, Nypaver TJ, Scully MM, Schmid DL.

J Vasc Surg. 2008 Feb;47(2):407-14. Epub 2007 Dec 26.

6.

Vascular access stenosis: comparison of arteriovenous grafts and fistulas.

Maya ID, Oser R, Saddekni S, Barker J, Allon M.

Am J Kidney Dis. 2004 Nov;44(5):859-65.

PMID:
15492952
7.

Access survival amongst hemodialysis patients referred for preventive angiography and percutaneous transluminal angioplasty.

Chan KE, Pflederer TA, Steele DJ, Lilly MP, Ikizler TA, Maddux FW, Hakim RM.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2669-80. doi: 10.2215/CJN.02860311. Epub 2011 Sep 29.

8.

The role of interventional radiology in management of patients with end-stage renal disease.

Surlan M, Popovic P.

Eur J Radiol. 2003 May;46(2):96-114. Review.

PMID:
12714226
10.

Flow monitoring: performance characteristics of ultrasound dilution versus color Doppler ultrasound compared with fistulography.

Schwarz C, Mitterbauer C, Boczula M, Maca T, Funovics M, Heinze G, Lorenz M, Kovarik J, Oberbauer R.

Am J Kidney Dis. 2003 Sep;42(3):539-45.

PMID:
12955682
11.

Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.

Sajgure A, Choudhury A, Ahmed Z, Choudhury D.

Nephrol Dial Transplant. 2007 May;22(5):1390-8. Epub 2007 Jan 31.

PMID:
17267534
12.

Colour Doppler ultrasound assessment of well-functioning mature arteriovenous fistulas for haemodialysis access.

Pietura R, Janczarek M, Zaluska W, Szymanska A, Janicka L, Skublewska-Bednarek A, Szczerbo-Trojanowska M.

Eur J Radiol. 2005 Jul;55(1):113-9. Epub 2004 Nov 19.

PMID:
15950108
13.

Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival.

Moist LM, Churchill DN, House AA, Millward SF, Elliott JE, Kribs SW, DeYoung WJ, Blythe L, Stitt LW, Lindsay RM.

J Am Soc Nephrol. 2003 Oct;14(10):2645-53.

14.

Expected flow parameters within hemodialysis access and selection for remedial intervention of nonmaturing conduits.

Back MR, Maynard M, Winkler A, Bandyk DF.

Vasc Endovascular Surg. 2008 Apr-May;42(2):150-8. doi: 10.1177/1538574407312648. Epub 2008 Feb 14.

PMID:
18276776
15.

The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.

Flu H, Breslau PJ, Krol-van Straaten JM, Hamming JF, Lardenoye JW.

J Vasc Surg. 2008 Sep;48(3):659-68. doi: 10.1016/j.jvs.2008.04.002. Epub 2008 Jun 24.

16.

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI; Dialysis Access Consortium Study Group.

JAMA. 2008 May 14;299(18):2164-71. doi: 10.1001/jama.299.18.2164.

17.

Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.

Slayden GC, Spergel L, Jennings WC.

Semin Dial. 2008 Sep-Oct;21(5):474-82. doi: 10.1111/j.1525-139X.2008.00459.x. Epub 2008 Jun 20.

PMID:
18627564
18.

Primary arteriovenous fistulas in the forearm for hemodialysis: effect of miscellaneous factors in fistula patency.

Erkut B, Unlü Y, Ceviz M, Becit N, Ateş A, Colak A, Koçak H.

Ren Fail. 2006;28(4):275-81.

PMID:
16771241
19.

Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW; Dialysis Outcomes and Practice Patterns Study.

Am J Kidney Dis. 2002 Dec;40(6):1255-63.

PMID:
12460045
20.

Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis.

Hingorani A, Ascher E, Kallakuri S, Greenberg S, Khanimov Y.

J Vasc Surg. 2001 Dec;34(6):1004-9.

Supplemental Content

Support Center